An update from Annovis Bio (ANVS) is now available.
Annovis Bio, Inc. has successfully exercised 0.8 million warrants issued in November 2023, resulting in a capital boost of $7.0 million through the issuance of roughly the same number of common shares. The transactions, which took place between July 8 and 9, 2024, were priced at $9.00 per share. This move represents a significant financial milestone for the company, reflecting investor confidence and providing funds for future endeavors.
Find detailed analytics on ANVS stock on TipRanks’ Stock Analysis page.